pyrroles has been researched along with Dry Eye in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, SK; Dana, R; Hua, J; Huang, JF; Kodati, S; Sadrai, Z; Stevenson, W | 1 |
| Foulks, GN; Klamerus, KJ; Li, JZ; Liew, SH; Nichols, KK; Zhang, M | 1 |
| Cooper, SR; Huang, JF; Liew, SH; McDowell, M; Pickering, EH; Rittenhouse, KD; Sace, F; Yafawi, R; Zhang, M | 1 |
2 trial(s) available for pyrroles and Dry Eye
| Article | Year |
|---|---|
Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
Topics: Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Female; Humans; Janus Kinase 3; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Surveys and Questionnaires; Tears; Treatment Outcome | 2012 |
Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.
Topics: Administration, Topical; Conjunctiva; Cyclosporine; Cytokines; Dry Eye Syndromes; Female; Flow Cytometry; HLA-DR1 Antigen; Humans; Janus Kinase 3; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Pyrimidines; Pyrroles; Tears | 2012 |
1 other study(ies) available for pyrroles and Dry Eye
| Article | Year |
|---|---|
Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity.
Topics: Adaptive Immunity; Administration, Topical; Animals; CD11b Antigen; Cell Movement; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Flow Cytometry; Gene Expression Regulation; Janus Kinase 3; Keratitis; Leukocyte Common Antigens; Leukocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ophthalmic Solutions; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Chemokine | 2014 |